Skip to content

Andrea Mckenzie

4 papers in the library · 114 citations · publishing 2022-2023

Papers

Sort Most recent Most cited

Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression.

Focus (American Psychiatric Publishing) October 1, 2023 Farhan Fancy, Nelson B Rodrigues, Joshua D. Di Vincenzo et al. 4 citations

Clinical trials have demonstrated rapid antidepressant effects with intravenous (IV) ketamine for major depressive disorder, with relatively less research specifically for bipolar depression. Herein, we describe the real-world effectiveness of repeated ketamine infusions for treatment-resistant bipolar depression. This study was conducted in a community clinic in Mississauga, Ontario (Canadian...

The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review.

Brain Sciences June 4, 2023 Muhammad Youshay Jawad, Saleha Qasim, Menglu Ni et al. 46 citations

Bipolar depression remains a clinical challenge with a quarter of patients failing to respond to initial conventional treatments. Although ketamine has been extensively studied in unipolar depression, its role in bipolar disorder remains inconclusive. The aim of our scoping review was to comprehensively synthesize the current clinical literature around ketamine use in bipolar depression. A...

Real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression

Bipolar Disorders December 14, 2022 Farhan Fancy, Nelson B Rodrigues, Joshua D. Di Vincenzo et al. 35 citations

Abstract Background Clinical trials have demonstrated rapid antidepressant effects with intravenous (IV) ketamine for major depressive disorder, with relatively less research specifically for bipolar depression. Herein, we describe the real‐world effectiveness of repeated ketamine infusions for treatment‐resistant bipolar depression. Methods This study was conducted in a community clinic in...

The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression.

Neuropharmacology November 1, 2022 Muhammad Youshay Jawad, Joshua D. Di Vincenzo, Sebastian Badulescu et al. 29 citations

Over the past two decades, ketamine has emerged as a novel effective and safe rapid-acting antidepressant. While the vast majority of studies on ketamine have focused on its ability to reduce the severity of depression broadly, its effectiveness in specific domains such as cognition, anhedonia, suicidality, and workplace/social/scholastic functionality has been neglected. Similarly, current...